Eli Lilly Solanezumab Immunization in Mild Alzheimer’s Disease Study
What is the Solanezumab in Mild Alzheimer’s Study?
The study is designed to test the long-term safety and efficacy of solanezumab in patients with mild Alzheimer's Disease.
What is the Purpose of the Solanezumab in Mild Alzheimer’s Study?
Solanezumab is an antibody that is thought to inhibit the buildup of beta-amyloid in the brain.
The study is ongoing at the Memory and Aging Clinic at Butler Hospital, but is no longer enrolling subjects
More information on other current research studies at Butler Hospital .